Losers: Hepion Pharmaceuticals (HEPA) -38% initiates wind-down activities in Phase 2b ‘ASCEND-NASH’ trial. Top Wealth Group Holding Limited (TWG) -17%. Redwoods Acquisition Corp (RWOD) -13%. Sunshine ...
Source LinkLosers: Hepion Pharmaceuticals (HEPA) -38% initiates wind-down activities in Phase 2b ‘ASCEND-NASH’ trial. Top Wealth Group Holding Limited (TWG) -17%. Redwoods Acquisition Corp (RWOD) -13%. Sunshine ...
Source Link
Comments